|
| |
|
|
| |
 |
Robert Gish, MD
University of California, San Diego
San Diego, CA |
|
| |
 |
|
| |
|
|
| |
 |
|
| |
|
|
|
|
|
Robert Gish, MD
University of California, San Diego
San Diego, CA
|
| Dr. Gish has received grants/research support from Bayer-Onyx, Bristol-Myers Squibb, Genentech/Hoffman-LaRoche, Gilead Sciences, Pharmasset, and ZymoGenetics. He has served as a consultant for Abbott, Anadys Pharmaceuticals, Inc., Bayer, Bristol-Myers Squibb, Durect, Hepahope, Hoffman-LaRoche Ltd., Genentech, Gilead Sciences, GlaxoSmithKline, GlobeImmune, Human Genome Sciences, Merck, Metabasis Therapeutics, OSI/Astellas, Pharmasset, Schering-Plough, Three Rivers, VitalTherapies, and ZymoGenetics. Dr. Gish has served on the speakers bureau for Bayer, Bristol-Myers Squibb, Hoffman-LaRoche Ltd., Gilead Sciences, GlaxoSmithKline, Onyx, Merck, Schering-Plough, Roche, Three Rivers, Salix and SciClone Pharmaceuticals.
|
| |
 |
| |
|
